Huge COVID Study Finds Remdesivir Doesn't Work--FDA Grants Approval Anyway
Source: Ars Technica
The US Food and Drug Administration on Thursday issued a full approval of the antiviral drug remdesivir for treating COVID-19just days after a massive global study concluded that the drug provides no benefit.
The FDA is committed to expediting the development and availability of COVID-19 treatments during this unprecedented public health emergency, FDA Commissioner Stephen Hahn said in a statement. Todays approval is supported by data from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the COVID-19 pandemic.
Early results
The FDA made its decision based on three clinical trials on remdesivir, a repurposed experimental antiviral drug brand-named Veklury. One was a randomized, double-blind, placebo-controlled trial run by the National Institute of Allergy and Infectious Diseases. It included 1,062 hospitalized COVID-19 patients, 541 of which received remdesivir. The trial concluded that remdesivir shortened the median recovery time from the infection from 15 days to 10 days. The researchers running the trial defined recovery of a patient as either a patient being discharged from the hospitalregardless if the patient still had lingering symptoms that limited activities or required supplemental oxygen to be taken at homeor a patient remaining in the hospital but no longer requiring medical care, such as if they were kept in the hospital for infection-control reasons.
The other two trials the FDA considered were conducted by Gilead, the company that makes remdesivir. One trial looked at about 600 people with moderate cases COVID-19. Patients were split into three groups, each about 200 peoplea group that got a 10-day course of remdesivir, a group that got a 5-day course, and a control group that got standard treatments. At day 11 of treatments, the group that had the 5-day course of remdesivir showed a statistically significant improvement in symptom scores compared with the control group. The group that got a 10-day course of remdesivir did not have a statistically significant improvement over the control group, though.
Read more: https://arstechnica.com/science/2020/10/fda-approves-remdesivir-for-covid-19-but-global-study-finds-it-doesnt-work/?comments=1
SunSeeker
(51,550 posts)Sucha NastyWoman
(2,748 posts)A drug didnt work on its intended disease. Lets see if we can find something else to sell it for.
If not well make it a supplement (non-regulated).
Is this any way to run a pharma industry?
melm00se
(4,991 posts)the drug is prescribed for something other than it's stated purpose. An example is Bupropion.
Commonly prescribed to quit smoking but also for weight loss which was one of the side effects.
ancianita
(36,030 posts)Move the product, get it PR'd to death everywhere, charge high prices and pay back its investors like Trump.
Maxheader
(4,373 posts)Has made a killing from corona...you betcha....
Omaha Steve
(99,597 posts)TheRickles
(2,057 posts)Just Google "Rumsfeld, Gilead". Dozens of articles describing crony capitalism at its finest.
LiberalArkie
(15,715 posts)Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2
A study conducted by researchers at Julius-Maximilians-Universität Würzburg has shown that the antidepressant agent fluoxetine may be an effective drug for the early treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among at-risk groups.
Jochen Bodem and colleagues found that the selective serotonin reuptake inhibitor (SSRI) fluoxetine significantly inhibited viral replication of SARS-CoV-2 and decreased viral protein expression in a specific manner.
The team points out that clinicians started using fluoxetine during the seventies and that the patent expired long ago. This well-studied drug that has been used to treat people for almost four decades is widely available and relatively cheap, they say.
https://www.news-medical.net/news/20200616/Antidepressant-fluoxetine-(Prozac)-suppresses-replication-of-SARS-CoV-2.aspx
JCMach1
(27,556 posts)In the Covid ICU... Literally a few hours from requiring a ventilator.
Scruffy1
(3,255 posts)oldsoftie
(12,533 posts)She also said that Hydroxichloroquine (sp) was stopped after 3 days because it made her feel like shit.
BlueIdaho
(13,582 posts)not_the_one
(2,227 posts)n/t